Clinical Characteristics and Mechanism Research of Deucravacitinib in the Idiopathic Inflammatory Myopathies

NCT07564271 · clinicaltrials.gov ↗

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Inflammatory Myopathies (IIMs)

Interventions

DRUG: Deucravacitinib 6mg po qd

Sponsor

Peking University People's Hospital